Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Spasmodic Dysphonia Patients' Perception of Pain With Botulinum Toxin Injections

NCT06767215 is registered in ClinicalTrials.gov with University of British Columbia as lead sponsor.

NCT NCT06767215
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06767215 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Spasmodic Dysphonia Patients' Perception of Pain With Botulinum Toxin Injections
Lead sponsor
University of British Columbia
Phase
Not applicable
Overall status
Completed
Start date
March 4, 2025
Completion date
January 25, 2026
Enrollment
116 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

spasmodic dysphonia